Maat Pharma raised €7.3M in a Series B round in Dec 2020. The company is based in Lyon, France. Investors in the round: PSIM Fund. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €7.3M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
